Chattha Anmol, Chen Austin D, Muste Justin, Cohen Justin B, Lee Bernard T, Lin Samuel J
From the Section of Plastic and Reconstructive Surgery, Department of Surgery, University of Chicago Medical Center, Chicago, IL.
Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
Ann Plast Surg. 2020 Oct;85(4):397-401. doi: 10.1097/SAP.0000000000002308.
Increased operative volume has been associated with benefits in patient outcomes for a variety of surgical procedures. In autologous abdominally based breast reconstruction, however, there are few studies assessing the association between procedure volume and patient outcomes. The objectives of this study are to evaluate the associations between abdominal-based free flap breast reconstruction and patient outcomes.
The 2013-2014 Healthcare Cost and Utilization Project National Inpatient Sample was queried for all female patients with a diagnosis of breast cancer who underwent mastectomy and immediate abdominally based breast reconstruction (deep inferior epigastric perforator or transverse rectus abdominus muscle free flaps). Outcomes included occurrence of major or surgical site in-hospital complications, hospital cost, and length of stay (LOS). High-volume (HV) hospitals were defined as the 90th percentile of annual case volume or higher (>18 cases/y). Multivariate regressions and generalized linear modeling with gamma log-link function were performed to access the outcomes associated with HV hospitals.
Overall, 7145 patients at 473 hospitals were studied; of these, 42.4% of patients were treated at HV hospitals. There were significant differences in unadjusted major complications (2.1% vs 4.3%; P < 0.001) and unadjusted surgical site complications (3.5% vs 6.1%; P < 0.001) between HV and non-HV hospitals. After adjustments for clinical and hospital characteristics, patients treated at HV hospitals were less likely to experience a major complication (odds ratio, 0.488; 95% confidence interval, 0.353-0.675; P < 0.001) or surgical site complication (odds ratio, 0.678; 95% confidence interval, 0.519-0.887; P = 0.005). There was no difference in inpatient cost between HV and non-HV hospitals ($26,822 vs $26,295; marginal cost, $528; P = 0.102); however, HV hospitals had a shorter LOS (4.31 vs 4.40 days; marginal LOS, -0.10 days; P = 0.005).
Hospitals that perform a larger volume of immediate abdominal-based breast reconstructions after mastectomy, when compared with those that perform a lower volume of these procedures, seem to have an associated lower rate of major complications and a shorter LOS. However, these same HV centers demonstrate no decrease in costs. Further research is needed to understand how these HV centers can reduce hospital costs.
手术量增加已被证明与多种外科手术的患者预后改善相关。然而,在自体腹部乳房重建手术中,评估手术量与患者预后之间关系的研究较少。本研究的目的是评估腹部游离皮瓣乳房重建手术与患者预后之间的关系。
查询2013 - 2014年医疗成本与利用项目国家住院患者样本,选取所有诊断为乳腺癌且接受了乳房切除术并立即进行腹部乳房重建(腹壁下深动脉穿支皮瓣或腹直肌肌皮瓣)的女性患者。观察指标包括主要或手术部位的院内并发症发生率、住院费用和住院时间(LOS)。高手术量(HV)医院定义为年度病例量处于第90百分位数及以上(>18例/年)的医院。采用多因素回归分析和具有伽马对数链接函数的广义线性模型来分析与HV医院相关的预后情况。
总体而言,对473家医院的7145例患者进行了研究;其中,42.4%的患者在HV医院接受治疗。HV医院与非HV医院在未经调整的主要并发症发生率(2.1%对4.3%;P < 0.001)和未经调整的手术部位并发症发生率(3.5%对6.1%;P < 0.001)方面存在显著差异。在对临床和医院特征进行调整后,在HV医院接受治疗的患者发生主要并发症的可能性较小(优势比,0.488;95%置信区间,0.353 - 0.675;P < 0.001)或手术部位并发症的可能性较小(优势比,0.678;95%置信区间,0.519 - 0.887;P = 0.005)。HV医院与非HV医院的住院费用无差异(26,822美元对26,295美元;边际成本,528美元;P = 0.102);然而,HV医院的住院时间较短(4.31天对4.40天;边际住院时间, - 0.10天;P = 0.005)。
与乳房切除术后进行腹部乳房重建手术量较低的医院相比,手术量较大的医院似乎主要并发症发生率较低且住院时间较短。然而,这些HV中心的成本并未降低。需要进一步研究以了解这些HV中心如何降低医院成本。